100+ years of groundbreaking research & advancement
From our founding in 1898, answering critical questions about cancer causes and treatments has been a core element of our mission at Roswell Park Comprehensive Cancer Center. We’re an international epicenter for major advances in diagnosis and treatment. And our work never ends.
With funding from the National Cancer Institute’s Cancer Center Support Grant (CCSG), Roswell Park makes new discoveries about cancer every day — how it grows, how to detect it, how to stop it.
And we do so much more. Developing new treatment standards. Training the next generation of scientists. Bringing new research into our communities and around the world.
Cancer research matters. We’re making a difference.
What does the “Comprehensive Cancer Center” designation mean?
Earning the National Cancer Institute's (NCI) Comprehensive Cancer Center designation shows that Roswell Park’s combined research, treatment and educational programs have weathered extensive peer review, met rigorous national standards, and made fundamental contributions to reducing the cancer burden.
Roswell Park is among a select group designated as a Comprehensive Cancer Center by the NCI and the only facility in upstate New York.
Our research focus
Our four major research programs at Roswell Park have unique missions, themes, goals, and investigative mechanisms. Our success relies on multidisciplinary collaboration across nearly every field of oncology and our state-of-the-art laboratories and shared resources.
Bringing new research into our communities
The CCSG programs at Rowell Park also work closely with our experts in community outreach, health disparities and cancer prevention to develop and offer integrated community-based services and educational programs tailored to meet the needs of vulnerable populations.
Training the next generation of scientists
In addition to our research and clinical trials, we’re also committed to training the next generation of basic and clinical scientists who will lead the way in tackling cancer.
Trainees in Roswell Park’s Master’s and PhD programs, along with our residents and clinical fellows, study closely with program members and participate in all phases of basic and translational research.
Earlier Access to New, Promising Treatments
Our translational research model speeds the progress of promising ideas from one phase of research to the next, through clinical trials that accelerate new treatments from the lab to the patients who need them.
Better Patient Outcomes
Three major studies found long-term survival rates improved 6% to 20% overall, and within specific cancer types, for patients treated from the start at NCI-designated comprehensive cancer centers, compared to those treated in other settings.
Sharing Our Knowledge
Roswell Park’s multidisciplinary teams share our knowledge of novel treatments, new ideas and inventive therapies with our fellow cancer experts locally and globally — every single day.
Investigators applying for Roswell Park Comprehensive Cancer Center membership must be salaried Roswell Park faculty members (professor, associate professor, assistant professor). Cancer Center members are typically aligned with only one Research Program. Program membership will be guided by the focus of an investigator’s grants and/or research interest and expertise.
They meet at least one of the following criteria:
- Has active, independent cancer-relevant peer-reviewed research funding or career development grant from an NCI-approved peer-reviewed funding organization
- Serve as a project leader on a qualifying multi-project research grant (P01, P50/ SPORE, U54)
- Serve as a clinical research leader having PI status on an interventional clinical trial or a peer-reviewed non-interventional trial
- Serve as a shared resource director
- Actively accrue patients to an investigator-initiated related clinical protocol. In these cases, the investigator should demonstrate substantive independent contributions to the research project, or clinical trial accrual with an emphasis on investigator-initiated and/or therapeutic trials, this includes investigators accruing and/or leading IIT or NCI-supported clinical trial networks, such as the National Clinical Trials Network (NCTN), the Early Therapeutic Clinical Trials Network (ETCTN), etc.
- Members will have opportunities to interact within and among each Research Program through monthly program meetings, seminars, PPG and SPORE Development groups and at the Annual Scientific Retreat
- Member biosketches will be reviewed by the CCSG Administrative Office; this will help target young and established investigators for potential cancer-relevant grants and awards
- All members have priority access to the shared resources, this includes preferential scheduling as well as reduced pricing on all CCSG sponsored shared resources
- All members are eligible to apply for internal Roswell Park research and pilot project funding opportunities subject to the individual application guidelines
Questions about membership
For questions about membership, please contact CCSG Administrator, Judith Epstein, at Judith.Epstein@RoswellPark.org.
Judith Epstein, MS, CRA
Dale Henry, MBA
Chief Scientific Operations Officer